Van Den Born Simon 4

4 · Marex Group plc · Filed Apr 2, 2026

AI-generated summary of this filing

Updated Apr 2, 2026

Marex Group (MRX) President Simon Van Den Born Sells Shares

What Happened

Simon Van Den Born, President of Marex Group plc (MRX), sold a total of 13,264 ordinary shares in two transactions on April 1, 2026. He sold 8,710 shares at a weighted average price of $43.27 for proceeds of $376,867, and 4,554 shares at a weighted average price of $43.97 for proceeds of $200,238 — total proceeds ≈ $577,105. These were sales (S), not purchases.

Key Details

Transaction date: 2026-04-01; Form 4 filed: 2026-04-02 (timely filing).
Prices/ranges: first lot weighted avg $43.27 (individual trades in that lot ranged $42.77–$43.7650); second lot weighted avg $43.97 (individual trades in that lot ranged $43.77–$44.29).
Total shares sold: 13,264; total proceeds ≈ $577,105.
Shares owned after transaction: not specified in the provided excerpt of the filing.
Notable footnotes:
- Sale was made under a pre-arranged Rule 10b5-1 trading plan entered Dec 12, 2025 (Footnote F1).
- Weighted-average prices and per-trade price ranges are disclosed; the reporting person will provide per-price sale counts on request (F2, F3).
- Filing notes 383,741 shares underlying deferred bonus awards previously granted to the reporting person (these are contingent awards that may convert to shares upon vesting) (F4).

Context

Because the sales were made under a Rule 10b5-1 plan, they were pre-scheduled trades and do not necessarily reflect the insider’s current view of the company. Sales are common for liquidity or tax-planning reasons; they are generally less informative about insider sentiment than purchases.

Form 4

Period: 2026-04-01

President

Transactions

Sale
Ordinary Shares
[F1][F2]
2026-04-01$43.27/sh−8,710$376,867→ 1,526,783 total
Sale
Ordinary Shares
[F1][F3][F4]
2026-04-01$43.97/sh−4,554$200,238→ 1,522,229 total

Footnotes (4)

[F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on December 12, 2025.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $42.77 to $43.7650 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $43.77 to $44.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The number of ordinary shares reported herein includes 383,741 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

Signature

/s/ Scott Linsley as Attorney-in-Fact, for Simon van den Born|2026-04-02

1 file